The story of clinical research is one of constant evolution. In the past decade, trials have evolved to include not just traditional drugs and medical devices, but also innovations like cell and gene therapies, wearables, and more.
As exciting as that growth may be, it invites more complexity. The focus of clinical research has expanded from life sciences companies and contract research organizations (CROs) to innovative stakeholders, including digital therapeutics, and biotechs focused on digital therapeutics and biomarker-focused companies.
As these new sponsors put their mark on the clinical research and development ecosystem, they have adopted technology designed to support automation, workflows, document management, and data collection. The trouble is these platforms are frequently sponsor-specific and vary widely from one trial to the next—creating a complex web of technology solutions that burden the clinical trial sites required to use them to support a given clinical trial.